Study of PlasmaCap IG in Adults and Children With PIDD
NCT03238079
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
74
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Immune Deficiency Diseases (PIDD)
Interventions
BIOLOGICAL:
10% IGIV
Sponsor
Evolve Biologics